Reviva Pharmaceuticals (RVPH) Short Interest Ratio & Short Volume $0.73 -0.05 (-6.88%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$0.75 +0.03 (+3.54%) As of 06/13/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Reviva Pharmaceuticals Short Interest DataReviva Pharmaceuticals (RVPH) has a short interest of 3.28 million shares, representing 13.47% of the float (the number of shares available for trading by the public). This marks a 7.89% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.9, indicating that it would take 4.9 days of the average trading volume of 1.16 million shares to cover all short positions.Current Short Interest3,280,000 sharesPrevious Short Interest3,040,000 sharesChange Vs. Previous Month+7.89%Dollar Volume Sold Short$3.18 millionShort Interest Ratio4.9 Days to CoverLast Record DateMay 31, 2025Outstanding Shares46,740,000 sharesShort Percent of Float13.47%Today's Trading Volume772,858 sharesAverage Trading Volume1,156,099 sharesToday's Volume Vs. Average67% Short Selling Reviva Pharmaceuticals? Sign up to receive the latest short interest report for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRVPH Short Interest Over TimeRVPH Days to Cover Over TimeRVPH Percentage of Float Shorted Over Time Reviva Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20253,280,000 shares $3.18 million +7.9%13.5%4.9 $0.97 5/15/20253,040,000 shares $2.55 million -9.8%12.5%4.2 $0.84 4/30/20253,370,000 shares $3.00 million -11.6%N/A3.7 $0.89 4/15/20253,810,000 shares $2.87 million +30.5%15.6%3.7 $0.75 3/31/20252,920,000 shares $2.79 million +2.5%12.0%2 $0.95 3/15/20252,850,000 shares $3.16 million -24.8%11.7%1.6 $1.11 2/28/20253,790,000 shares $5.46 million -10.8%15.6%1.3 $1.44 2/15/20254,250,000 shares $7.65 million -15.7%17.5%1.5 $1.80 1/31/20255,040,000 shares $9.53 million -3.5%N/A1.8 $1.89 1/15/20255,220,000 shares $9.45 million -7.5%N/A2 $1.81 Get the Latest News and Ratings for RVPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/20245,640,000 shares $10.21 million -35.9%N/A2.4 $1.81 12/15/20248,800,000 shares $22.97 million +42.9%N/A4.6 $2.61 11/30/20246,160,000 shares $7.64 million -4.2%N/A6.4 $1.24 11/15/20246,430,000 shares $7.23 million +21.3%N/A14 $1.13 10/31/20245,300,000 shares $5.94 million -0.2%N/A10.6 $1.12 10/15/20245,310,000 shares $6.53 million -2.9%N/A11.1 $1.23 9/30/20245,470,000 shares $7.88 million -5.7%N/A11.5 $1.44 9/15/20245,800,000 shares $6.96 million +6.2%N/A12.4 $1.20 8/31/20245,460,000 shares $6.12 million +23.0%N/A12.3 $1.12 8/15/20244,440,000 shares $3.04 million -0.2%N/A10.7 $0.69 7/31/20244,450,000 shares $5.21 million +22.9%N/A14.1 $1.17 7/15/20243,620,000 shares $4.42 million +16.4%N/A12.8 $1.22 6/30/20243,110,000 shares $3.98 million +1.0%N/A12.4 $1.28 6/15/20243,080,000 shares $4.50 million -2.2%N/A10.6 $1.46 5/31/20243,150,000 shares $4.32 million +77.0%N/A9.8 $1.37 5/15/20241,780,000 shares $3.04 million +42.4%N/A5.9 $1.71 4/30/20241,250,000 shares $3.83 million +1.6%N/A4.6 $3.06 4/15/20241,230,000 shares $4.28 million +16.0%N/A4.1 $3.48 3/31/20241,060,000 shares $4.01 million +62.9%N/A3.2 $3.78 3/15/2024650,700 shares $2.05 million -24.2%N/A1.5 $3.15 2/29/2024858,100 shares $3.27 million -15.9%N/A2 $3.81 2/15/20241,020,000 shares $4.38 million +21.5%N/A2.3 $4.29 1/31/2024839,800 shares $3.26 million +14.7%N/A1.6 $3.88 1/15/2024732,400 shares $3.05 million -20.9%N/A0.6 $4.17 12/31/2023925,900 shares $4.77 million +2.6%N/A0.7 $5.15 12/15/2023902,300 shares $3.41 million -47.5%N/A0.7 $3.78 11/30/20231,720,000 shares $6.59 million -48.0%N/A1.5 $3.83 11/15/20233,310,000 shares $16.55 million +30.8%N/A3 $5.00 10/31/20232,530,000 shares $11.87 million +42.9%N/A2.5 $4.69 10/15/20231,770,000 shares $7.98 million +5.4%N/A9.8 $4.51Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again. 9/30/20231,680,000 shares $8.20 million +14.3%N/A10.4 $4.88 9/15/20231,470,000 shares $8.01 million +14.0%N/A8.9 $5.45 8/31/20231,290,000 shares $5.04 million -2.3%N/A7.3 $3.91 8/15/20231,320,000 shares $5.64 million +4.8%N/A6.7 $4.27 7/31/20231,260,000 shares $5.97 million +1.6%N/A6.4 $4.74 7/15/20231,240,000 shares $6.31 million No ChangeN/A5.2 $5.09 6/30/20231,240,000 shares $7.27 million -18.4%N/A5.4 $5.86 6/15/20231,520,000 shares $9.45 million -1.9%N/A7.3 $6.22 5/31/20231,550,000 shares $9.47 million -4.9%N/A8.4 $6.11 5/15/20231,630,000 shares $13.02 million +20.7%N/A10.8 $7.99 4/30/20231,350,000 shares $9.25 million +22.7%N/A9.8 $6.85 4/15/20231,100,000 shares $5.26 million +11.9%N/A10 $4.78 3/31/2023982,800 shares $4.12 million +13.9%N/A10.1 $4.19 3/15/2023863,200 shares $3.45 million +9.8%N/A7 $4.00 2/28/2023786,500 shares $3.69 million +0.4%N/A5.3 $4.69 2/15/2023783,200 shares $3.54 million -5.3%N/A4.6 $4.53 1/31/2023827,100 shares $3.94 million -11.9%N/A3.4 $4.76 1/15/2023938,300 shares $4.12 million -2.6%N/A2.8 $4.39 12/30/2022963,400 shares $4.09 million -6.5%N/A2.2 $4.25 12/15/20221,030,000 shares $4.23 million No ChangeN/A2.2 $4.11 11/30/20221,030,000 shares $3.78 million -15.6%N/A1.9 $3.67 11/15/20221,220,000 shares $4.84 million +49.4%N/A0.9 $3.97 10/31/2022816,600 shares $3.20 million -8.4%N/A0.5 $3.92 10/15/2022891,100 shares $3.15 million +24.1%N/A0.5 $3.54 9/30/2022717,800 shares $1.14 million -9.9%N/A0.5 $1.59 9/15/2022796,300 shares $1.86 million -20.4%N/A0.5 $2.34 8/31/20221,000,000 shares $2.19 million +299.0%N/A0.7 $2.19 8/15/2022250,600 shares $205.49 thousand -72.0%N/A0.5 $0.82 7/31/2022894,200 shares $568.62 thousand +77.8%N/A4.2 $0.64 7/15/2022502,800 shares $507.83 thousand +77.5%N/A8.4 $1.01 6/30/2022283,200 shares $311.52 thousand +109.6%N/A5.2 $1.10 6/15/2022135,100 shares $160.77 thousand +24.6%N/A2.3 $1.19 5/31/2022108,400 shares $192.95 thousand +130.2%N/A1.8 $1.78 5/15/202247,100 shares $70.41 thousand -62.6%N/A0.7 $1.50 4/30/2022126,000 shares $263.34 thousand +1.0%N/A1.7 $2.09 4/15/2022124,700 shares $271.85 thousand -29.5%N/A0.9 $2.18 3/31/2022176,800 shares $434.93 thousand +340.9%N/A0.3 $2.46 3/15/202240,100 shares $68.97 thousand -64.5%N/A0.1 $1.72 2/28/2022112,800 shares $217.70 thousand -19.3%N/A0.2 $1.93 2/15/2022139,800 shares $248.84 thousand +6.9%N/A0.2 $1.78 1/31/2022130,800 shares $221.05 thousand -15.8%N/A0.2 $1.69 1/15/2022155,300 shares $315.26 thousand +84.9%1.8%0.3 $2.03 12/31/202184,000 shares $242.76 thousand +234.7%1.0%0.2 $2.89 12/15/202125,100 shares $84.09 thousand -79.7%0.3%0.4 $3.35 11/30/2021123,700 shares $449.03 thousand +4.9%1.5%1.9 $3.63 11/15/2021117,900 shares $433.87 thousand +1.5%1.4%1.6 $3.68 10/29/2021116,200 shares $406.70 thousand +16.4%1.5%1.1 $3.50 10/15/202199,800 shares $374.25 thousand +17.1%1.4%0.9 $3.75 9/30/202185,200 shares $346.76 thousand -20.7%1.2%0.7 $4.07 9/15/2021107,500 shares $445.05 thousand +69.0%1.5%0.9 $4.14Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again. 8/31/202163,600 shares $279.84 thousand +45.2%0.9%0.5 $4.40 8/13/202143,800 shares $153.30 thousand -13.1%1.1%0.4 $3.50 7/30/202150,400 shares $176.40 thousand -19.1%1.8%0.4 $3.50 7/15/202162,300 shares $256.05 thousand -5.3%2.2%0 $4.11 6/30/202165,800 shares $319.79 thousand -5.5%2.3%0 $4.86 6/15/202169,600 shares $329.21 thousand -82.9%2.4%0 $4.73 5/28/2021406,500 shares $2.03 million +73.9%12.0%0.3 $5.00 5/14/2021233,800 shares $1.10 million -12.1%4.1%0.2 $4.69 4/30/2021265,900 shares $1.56 million +3,265.8%4.7%0.2 $5.88 4/15/20217,900 shares $33.97 thousand -27.5%0.1%0 $4.30 3/31/202110,900 shares $61.59 thousand +240.6%0.2%0.3 $5.65 3/15/20213,200 shares $27.14 thousand -51.5%0.1%0.1 $8.48 2/26/20216,600 shares $61.05 thousand -9.6%0.1%0.1 $9.25 2/12/20217,300 shares $64.90 thousand +170.4%0.1%0.1 $8.89 1/29/20212,700 shares $21.41 thousand -91.5%0.1%0.1 $7.93 1/15/202131,800 shares $294.15 thousand No Change0.6%0.6 $9.25 RVPH Short Interest - Frequently Asked Questions What is Reviva Pharmaceuticals' current short interest? Short interest is the volume of Reviva Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 3,280,000 shares of RVPH short. 13.47% of Reviva Pharmaceuticals' shares are currently sold short. Learn More on Reviva Pharmaceuticals' current short interest. What is a good short interest ratio for Reviva Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RVPH shares currently have a short interest ratio of 5.0. Learn More on Reviva Pharmaceuticals's short interest ratio. Which institutional investors are shorting Reviva Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Reviva Pharmaceuticals: Quaker Wealth Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Reviva Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.47% of Reviva Pharmaceuticals' floating shares are currently sold short. Is Reviva Pharmaceuticals' short interest increasing or decreasing? Reviva Pharmaceuticals saw a increase in short interest during the month of May. As of May 31st, there was short interest totaling 3,280,000 shares, an increase of 7.9% from the previous total of 3,040,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Reviva Pharmaceuticals' short interest compare to its competitors? 13.47% of Reviva Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Reviva Pharmaceuticals: Puma Biotechnology, Inc. (7.44%), SELLAS Life Sciences Group, Inc. (17.57%), Janone Inc. (3.01%), LifeVantage Co. (19.68%), Prime Medicine, Inc. (34.74%), Aclaris Therapeutics, Inc. (7.03%), Spero Therapeutics, Inc. (6.69%), Molecular Partners AG (0.11%), Inhibikase Therapeutics, Inc. (2.36%), Fate Therapeutics, Inc. (10.21%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Reviva Pharmaceuticals stock? Short selling RVPH is an investing strategy that aims to generate trading profit from Reviva Pharmaceuticals as its price is falling. RVPH shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Reviva Pharmaceuticals? A short squeeze for Reviva Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RVPH, which in turn drives the price of the stock up even further. How often is Reviva Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RVPH, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies PBYI Short Interest Data SLS Short Interest Data ALTS Short Interest Data LFVN Short Interest Data PRME Short Interest Data ACRS Short Interest Data SPRO Short Interest Data MOLN Short Interest Data IKT Short Interest Data FATE Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RVPH) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reviva Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
